Check out the latest features and columns!

Pharmaceutical Executive November 2022

November's Executive Profile features Christi Shaw, CEO of Kite

A Mission of the Heart

Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences stakeholders

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Pharm Exec profiles its 2022 Emerging Pharma Leaders

Pharm Exec's 2022 Emerging Pharma Leaders

 The windfall from COVID-19 vaccines and treatments has shaken up Pharm Exec’s latest listing of the top global biopharma sales producers in record-breaking fashion

2022 Pharm Exec 50

 and can be reached at fpollaro@mjhlifesciences.com.

Podcasts

In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.

Tuning Into CTV - Real Time Data For Marketers

Articles

Incyte Biosciences United Kingdom and Ireland Appoints Peter Williams As General Manager

This is the intelligence company's fifth acquisition.

CorEvitas Acquires Pregnancy Data Registry Pregistry

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.

How Clinical Trials Can Thrive in the Digital Era

Healthcare marketing leader Lasso powers a unique endemic HCP campaign, reaching 70% more providers than the benchmark and fueling 30% lift in new prescription activity.

Lasso's Endemic Marketplace Unlocks Elusive HCPs for BioPharm Communications

The partnership enables clinical trial sponsors to pressure test protocol designs with Savvy Cooperative patients through ProofPilot's digital protocol interface.

ProofPilot Announces Strategic Partnership with Savvy Cooperative

Peter A. Vaccaro is the market access strategist for Formulary Insights.

A clearer understanding of the Inflation Reduction Act’s implications is needed for manufacturers to plot a successful course forward.

Biopharma Leaders Prepare to Navigate Medicare’s New Negotiating Power

New regulations may require regulators to explore new payment options.

Instead of Drug Spending Caps, Medicare Should Try Value-Based Contracting

Nearly 7,000 researchers from across the globe received designations.

Clarivate Names Highly Cited Researcher 2022 Designations

The move reflects Fingerpaint Group's commitment to innovate its capabilities as clients' needs evolve.

Featured Content

Pharmaceutical Executive November 2022

A Mission of the Heart

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Pharm Exec's 2022 Emerging Pharma Leaders

2022 Pharm Exec 50